The following table provides information about the project.
|Coordinator Country||Netherlands [NL]|
|Total cost||5˙105˙105 €|
|EC max contribution||4˙352˙007 € (85%)|
1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
|Duration (year-month-day)||from 2017-01-01 to 2020-12-31|
Take a look of project's partnership.
|1||UNIVERSITEIT TWENTE||NL (ENSCHEDE)||coordinator||864˙375.00|
|2||PA IMAGING R&D BV||NL (ENSCHEDE)||participant||816˙000.00|
|3||IMASONIC SAS||FR (VORAY SUR L'OGNON)||participant||760˙000.00|
|4||UNIVERSITY COLLEGE LONDON||UK (LONDON)||participant||708˙663.00|
|5||EKSPLA UAB||LT (VILNIUS)||participant||410˙468.00|
|6||VYSOKE UCENI TECHNICKE V BRNE||CZ (BRNO STRED)||participant||385˙000.00|
|7||TP21 GMBH||DE (BERLIN)||participant||222˙500.00|
|8||STICHTING MEDISCH SPECTRUM TWENTE||NL (ENSCHEDE)||participant||185˙000.00|
|9||UNIVERSITAET BERN||CH (BERN)||participant||0.00|
X-ray mammography is the mainstay of breast cancer screening programs. It is estimated that between 20 - 50% of abnormal screening mammograms will prove to be negative. The paradigm in diagnosis is to establish whether a lesion is benign or malignant. All the imaging techniques conventionally used today – diagnostic x-ray, ultrasonography and magnetic resonance imaging have many limitations, leading to multiple and/or repeat imaging and often unnecessary biopsy. This leads to physical, psychological and economic burdens felt at individual, familial and societal levels.
With an aging population, high incidence of breast cancer and tightening health-care budgets, there is an urgent requirement for a non-invasive method for in-depth assessment of the screening-detected lesion. In PAMMOTH we will showcase such an imager, combining photoacoustic and ultrasound imaging. With the use of quantitative image reconstruction of multi-wavelength photoacoustic data, information is gained of the vascular and oxygen status of the lesion relating to tumor physiology and function. From the ultrasound part, we derive ultrasound reflection from the lesion in a manner superior to conventional breast ultrasonography, relating to anatomic features and extent of a tumor. This information will enable the radiologist to come to a diagnosis accurately and rapidly without the use of contrast agents, without pain and discomfort to the patient, while being cost-effective and not requiring complex infrastructure.
Four excellent academic groups, three dynamic SMEs, and a hospital come together with support from key stakeholders in an Advisory group, to push beyond the state-of-the-art in science and technology to achieve the PAMMOTH imager. For the SMEs, in addition to tremendous improvements in individual product lines, the new integrated diagnostic imaging instrument opens up completely new market opportunities.
We expect PAMMOTH to have a strong economic and clinical impact.
Work performed, outcomes and results: advancements report(s)
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PAMMOTH" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "PAMMOTH" are provided by the European Opendata Portal: CORDIS opendata.
Multi-modal, multi-scale retinal imagingRead More
Real-time Content Analysis and Processing (ReCAP) for Agile Media ProductionRead More
Boosting the growth potential of CEE start-ups on a pan-Europen level by creating new opportunities, synergies and opening the GATE of Startup Europe to the BalkansRead More